AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Nunchiglim-M 1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Nunchi Pharma Pvt. Ltd.

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Nunchiglim-M 1 Tablet PR

Dia-Comb 1 Tablet PR, an anti-diabetic medication, combines two active ingredients to manage type 2 diabetes in adults. This formulation helps regulate blood glucose. Dia-Comb 1 Tablet PR should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continue taking this medicine as prescribed, even if feeling well, as discontinuation without medical consultation can lead to elevated blood sugar, increasing the risk of kidney complications, vision loss, neuropathy, and limb amputation. Remember, this medication is part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are crucial for diabetes control. The most frequent adverse effect is hypoglycemia (low blood sugar). Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to treat them. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be limited due to its potential to worsen hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. Do not use Dia-Comb 1 Tablet PR if you have type 1 diabetes, diabetic ketoacidosis, or severe kidney or liver impairment. Inform your physician of any history of heart disease before starting this medication; it may not be appropriate in all cases. Pregnant or breastfeeding individuals should seek medical advice prior to use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are typically recommended.

Uses of Nunchiglim-M 1 Tablet PR

Managing Type 2 Diabetes

Major Benefits of Nunchiglim-M 1 Tablet PR:

Follow your doctor's instructions or consult the product label for proper administration. Take one Nunchiglim-M tablet (PR) with a meal.

Common Side effects of Nunchiglim-M 1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Nunchiglim-M 1 Tablet PR:

Follow your doctor's instructions or refer to the product label for usage guidance. Administer one Nunchiglim-M tablet (PR) with a meal.

How Nunchiglim-M 1 Tablet PR works:

Nunchiglim-M, a single-dose tablet, combines glimepiride and metformin to manage type 2 diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Nunchiglim-M 1 Tablet PR is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Nunchiglim-M 1 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Consult your doctor for advice.

Breast feedingBreast feedingUNSAFE

Lactation and Nunchiglim-M 1 Tablet PR are incompatible. Evidence indicates potential infant toxicity associated with this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Nunchiglim-M 1 Tablet PR cautiously, potentially requiring a modified dosage. Severe kidney disease contraindicates the use of Nunchiglim-M 1 Tablet PR. Physician consultation is advised. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Nunchiglim-M 1 Tablet PR cautiously, potentially requiring dosage modification. Consult a physician for guidance. A reduced initial dose is typically advised for those with mild to moderate liver disease; the medication is unsuitable for individuals with severe hepatic dysfunction.

What if you forget to take Nunchiglim-M 1 Tablet PR :

Should you forget a dose of Nunchiglim-M 1 Tablet PR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Nunchiglim-M 1 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Nunchiglim-M 1 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Nunchiglim-M 1 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Nunchiglim-M 1 Tablet PR and seek immediate medical attention.
Nunchiglim-M 1 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Nunchiglim-M 1 Tablet PR may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Nunchiglim-M 1 Tablet PR use can lead to Vitamin B12 deficiency by hindering its stomach absorption. This deficiency, if left untreated, may result in anemia, neurological issues (including tingling, numbness in extremities, weakness, and ataxia), urinary problems, and cognitive changes. To mitigate this risk, supplemental Vitamin B12 intake is recommended at least annually, according to some research.
Nunchiglim-M 1 Tablet PR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Nunchiglim-M 1 Tablet PR with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Nunchiglim-M 1 Tablet PR
48
MRP 59
17% off